PEMF Assists in BPH Battle
Five minutes, twice a day for three weeks. That was the time needed to reduce prostate sizes in 20 dogs by 57 percent using PEMF, pulsed electromagnetic frequency. Each of the dogs had been diagnosed with benign prostatic hyperplasia (BPH).
The reduction in prostatic volume showed no adverse effect on semen quality, testosterone levels, nor libido, which were among the factors assessed before and after the study.
The conclusion of the study’s investigators was that:
“The efficacy of PEMF on BPH in dogs, with no side effects, suggests the suitability of this treatment in humans and supports the hypothesis that impairment of blood supply to the lower urinary tract may be a causative factor in the development of BPH.”
A study of 68- to 78-year-old men in 2011 also demonstrated the effectiveness of PEMF in battling BPH.
In this study, 20 men were randomly assigned to a group receiving PEMF five consecutive days for two weeks, or a group receiving an A-blocker (Alfuzosin, 10 mg/24 h) for four weeks.
Both groups improved International Prostate Symptom Score (IPSS), but the PEMF group also improved prostate volume, urine residue, and mean urine flow rate.
“Follow-up of the patients of this group for one year revealed that results obtained by EMFs treatment are still remaining,” the study reported.
One of my colleagues in Florida, Dr. Robert Gilliland, collected a testimonial from a client for whom PEMF made an enormous difference in his battle with BPH.
 Leoci, Raffaella et al. “Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in the Treatment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Model.” The Prostate 74.11 (2014): 1132–1141. PMC. Web. 24 Jan. 2017.
 Giannakopoulos, X.K., Giotis, C., Karkabounas, S.C. et al. Int Urol Nephrol (2011) 43: 955. doi:10.1007/s11255-011-9944-7